Development and validation of a specific stability indicating high performance liquid chromatographic method for valsartan.
A stability-indicating HPLC assay method has been developed and validated for valsartan in bulk drug and pharmaceutical dosage forms. An isocratic RP-HPLC was achieved on Waters 2695 using Symmetry C18 (250mm × 4.6mm × 5μ) column with the mobile phase consisting of 0.02 mM sodium dihydrogen ortho-phosphate, pH adjusted to 2.5 using ortho-phosphoric acid (solvent A), and acetonitrile (solvent B) in the ratio of 58:42 %v/v. The stress testing of valsartan was carried out under acidic, alkaline, oxidative, thermal, and photolytic conditions. Valsartan was well resolved from its degradation products. The proposed method was validated as per ICH guidelines. The method was found to be suitable for the quality control of valsartan in bulk and pharmaceutical dosage forms as well as the stability-indicating studies.
Roland Institute of Pharmaceutical Sciences, Berhampur-760010, Orissa, India.
Ks
K
Rao
N
N
Jena
Meb
M
Rao
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15;858(1-2):143-50
17884739
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 17;832(1):169-72
16426905
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):345-9
11824822
J Chromatogr A. 2002 Mar 8;949(1-2):49-60
11999756
J Chromatogr B Biomed Appl. 1996 Nov 8;686(1):77-83
8953194
J Pharm Biomed Anal. 2007 Apr 11;43(5):1769-74
17289324
J Pharm Biomed Anal. 2001 Jul;25(5-6):1009-13
11377086
J Pharm Biomed Anal. 2001 Dec;26(5-6):891-7
11600301
J Pharm Biomed Anal. 2002 Sep 5;30(2):371-5
12191724